|
1
|
Einhorn LH: Treatment of testicularcancer:
A new and improved model. J Clin Oncol. 8:1777–1781. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Einhorn LH: General Motors Research
Prizewinners Laureates Lectures. Charles F. Kettering Prize.
Clinical trials in testicular cancer. Cancer. 71:3182–3184.
1993.PubMed/NCBI
|
|
3
|
Motzer RJ, Amsterdam A, Prieto V,
Sheinfeld J, Murty VV, Mazumdar M, Bosl GJ, Chaganti RS and Reuter
VE: Teratoma with malignant transformation: Diverse malignant
histologies arising in men with germ cell tumors. J Urol.
159:133–138. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Motzer RJ, Sheinfeld J, Mazumdar M, Bains
M, Mariani T, Bacik J, Bajorin D and Bosl GJ: Paclitaxel,
ifosfamide, and cisplatin second-line therapy for patients with
relapsed testicular germ cell cancer. J Clin Oncol. 18:2413–2418.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mardiak J, Salek T, Sycova-Mila Z,
Obertova J, Hlavata Z, Mego M, Reckova M and Koza I: Paclitaxel
plus ifosfamide and cisplatin in second-line treatment of germ cell
tumors: A phase II study. Neoplasma. 52:497–501. 2005.PubMed/NCBI
|
|
6
|
De Giorgi U, Rosti G, Papiani G and
Marangolo M: The status of high-dose chemotherapy with
hematopoietic stem cell transplantation in germ cell tumor
patients. Haematologica. 87:95–104. 2002.PubMed/NCBI
|
|
7
|
Feldman DR, Patil S, Trinos MJ, Carousso
M, Ginsberg MS, Sheinfeld J, Bajorin DF, Bosl GJ and Motzer RJ:
Progression-free and overall survival in patients with
relapsed/refractory germ cell tumors treated with single-agent
chemotherapy: Endpoints for clinical trial design. Cancer.
118:981–986. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Oechsle K, Kollmannsberger C, Honecker F,
Mayer F, Waller CF, Hartmann JT, Boehlke I and Bokemeyer C; and
German Testicular Cancer Study Group, : Long-term survival after
treatment with gemcitabine and oxaliplatin with and without
paclitaxel plus secondary surgery in patients with cisplatin-
refractory and/or multiply relapsed germ cell tumors. Eur Urol.
60:850–855. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mego M, Svetlovska D, Miskovska V,
Obertova J, Palacka P, Rajec J, Sycova-Mila Z, Chovanec M,
Rejlekova K, Zuzák P, et al: Phase II study of everolimus in
refractory testicular germ cell tumors. Urol Oncol. 34(122):
e17–e22. 2016.
|
|
10
|
Daniel VC, Marchionni L, Hierman JS,
Rhodes JT, Devereux WL, Rudin CM, Yung R, Parmigiani G, Dorsch M,
Peacock CD and Watkins DN: A primary xenograft model of small-cell
lung cancer reveals irreversible changes in gene expression imposed
by culture in vitro. Cancer Res. 69:3364–3373. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Siolas D and Hannon GJ: Patient derived
tumor xenografts: Transforming clinical samples into mouse models.
Cancer Res. 73:5315–5319. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Choi YY, Lee JE, Kim H, Sim MH, Kim KK,
Lee G, Kim HI, An JY, Hyung WJ, Kim B, et al: Establishment and
characterization of patient-derived xenografts as paraclinical
models for gastric cancer. Sci Rep. 6:221722016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Fichtner I, Slisow W, Gill J, Becker M,
Elbe B, Hilebrand T and Bibby M: Anticancer drug response and
expression of molecular markers in early-passage xenotransplanted
colon carcinomas. Eur J Cancer. 40:298–307. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Rubio-Viqueira B and Hidalgo M: Direct in
vivo xenograft tumor model for predicting chemotherapeutic drug
response in cancer patients. Clin Pharmacol Ther. 85:217–221. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
DeRose YS, Wang G, Lin YC, Bernard PS,
Buys SS, Ebbert MT, Factor R, Matsen C, Milash BA, Nelson E, et al:
Tumor grafts derived from women with breast cancer authentically
reflect tumor pathology, growth, metastasis and disease outcomes.
Nat Med. 17:1514–1520. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhao X, Liu Z, Yu L, Zhang Y, Baxter P,
Voicu H, Gurusiddappa S, Luan J, Su JM, Leung HC and Li XN: Global
gene expression profiling confirms the molecular fidelity of
primary tumor-based orthotopic xenograft mouse models of
medulloblastoma. Neuro Oncol. 14:574–583. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Houghton JA, Houghton PJ and Green AA:
Chemotherapy of childhood rhabdomyosarcomas growing as xenografts
in immune-deprived mice. Cancer Res. 42:535–539. 1982.PubMed/NCBI
|
|
18
|
Talmadge JE, Singh RK, Fidler IJ and Raz
A: Murine models to evaluate novel and conventional therapeutic
strategies for cancer. Am J Pathol. 170:793–804. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Abraham D, Abri S, Hofmann M, Höltl W and
Aharinejad S: Low dose carboplatin combined with angiostatic agents
prevents metastasis in human testicular germ cell tumor xenografts.
J Urol. 170:1388–1393. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Castillo-Avila W, Piulats JM, Del Muro
Garcia X, Vidal A, Condom E, Casanovas O, Mora J, Germà JR, Capellà
G, Villanueva A and Viñals F: Sunitinib inhibits tumor growth and
synergizes with cisplatin in orthotopic models of
cisplatin-sensitive and cisplatin-resistant human testicular germ
cell tumors. Clin Cancer Res. 15:3384–3395. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
de Vries G, Rosas-Plaza X, van Vugt MA,
Suurmeijer A, Gietema JA and de Jong S: Development of testicular
cancer patient derived xenograft models to test combination
therapies targeting PI3K/Akt and MDM2. Cancer Res. 77 Suppl
13:38612017. View Article : Google Scholar
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Matuskova M, Kozovska Z, Toro L,
Durinikova E, Tyciakova S, Cierna Z, Bohovic R and Kucerova L:
Combined enzyme/prodrug treatment by genetically engineered AT-MSC
exerts synergy and inhibits growth of MDA-MB-231 induced lung
metastases. J Exp Clin Cancer Res. 34:332015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Némati F, Sastre-Garau X, Laurent C,
Couturier J, Mariani P, Desjardins L, Piperno-Neumann S, Lantz O,
Asselain B, Plancher C, et al: Establishment and characterization
of a panel of human uveal melanoma xenografts derived from primary
and/or metastatic tumors. Clin Cancer Res. 16:2352–2362. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sivanand S, Peña-Llopis S, Zhao H,
Kucejova B, Spence P, Pavia-Jimenez A, Yamasaki T, McBride DJ,
Gilen J, Wolff NC, et al: A validated tumor graft model reveals
activity of dovitinib against renal cell carcinoma. Sci Transl Med.
4:137ra752012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang X, Fu X and Hoffman RM: A new
patient-like metastatic model of human lung cancer constructed
orthotopically with intact tissue via thoracotomy in
immunodeficient mice. Int J Cancer. 51:992–995. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Shuhendler AJ, Prasad P, Cai P, Hui KK,
Henderson JT, Rauth AM and Wu XY: Matrigel alters the
pathophysiology of orthotopic human breast adenocarcinoma
xenografts with implications for nanomedicine evaluation.
Nanomedicine. 9:795–805. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Read M, Liu D, Duong CP, Cullinane C,
Murray WK, Fennell CM, Shortt J, Westerman D, Burton P, Clemons NJ
and Phillips WA: Intramuscular transplantation improves engraftment
rates for esophageal patient-derived tumor xenografts. Ann Surg
Oncol. 23:305–311. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Fujii E, Suzuki M, Matsubara K, Watanabe
M, Chen YJ, Adachi K, Ohnishi Y, Tanigawa M, Tsuchiya M and Tamaoki
N: Establishment and characterization of in vivo human tumor models
in the NOD/SCID/gamma(c)(null) mouse. Pathol Int. 58:559–567. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Krege S, Beyer J, Souchon R, Albers P,
Albrecht W, Algaba F, Bamberg M, Bodrogi I, Bokemeyer C,
Cavallin-Ståhl E, et al: European consensus conference on diagnosis
and treatment of germ cell cancer: A report of these condmeeting of
the european germ cell cancer consensus group (EGCCCG): Part I. Eur
Urol. 53:478–496. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Beck SD and Foster RS: Long-term outcome
of retroperitoneal lymph node dissection in the management of
testis cancer. World J Urol. 24:267–272. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Oldenburg J, Alfsen GC, Lien HH, Aas N,
Waehre H and Fossa SD: Postchemotherapy retroperitoneal surgery
remains necessary in patients with nonseminomatous testicular
cancer and minimal residual tumor masses. J Clin Oncol.
21:3310–3317. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Brandli DW, Ulbright TM, Foster RS,
Cummings OW, Zhang S, Sweeney CJ, Eble JN and Cheng L: Stroma
adjacent to metastatic mature teratoma after chemotherapy for
testicular germ cell tumors is derived from the same progenitor
cells as the teratoma. Cancer Res. 63:6063–6068. 2003.PubMed/NCBI
|
|
34
|
Nettersheim D, Westernstroer B, Gillis
AJM, Looijenga LHJ, Schlatt S and Schorle H: Chanages in the
microenviroment affect differentiation of the seminoma cell line
TCam-2 and infusion into the mouse testis provides a model for the
study CIS. 7th Copenhagen Workshop on CIS-Testis and Germ Cell
Cancer Abstracts: abs. 24:2010.
|
|
35
|
Prochazka M, Gaskins HR, Shultz LD and
Leiter EH: The nonobese diabetic scid mouse: Model for spontaneous
thymomagenesis associated with immunodeficiency. Proc Natl Acad Sci
USA. 89:3290–3294. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhang L, Liu Y, Wang X, Tang Z, Li S, Hu
Y, Zong X, Wu X, Bu Z, Wu A, et al: The extent of inflammatory
infiltration in primary cancer tissues is associated with
lymphomagenesis in immunodeficient mice. Sci Rep. 5:94472015.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
John T, Yanagawa N, Kohler D, Craddock KJ,
Bandarchi-Chamkhaleh B, Pintilie M, Sykes J, To C, Li M, Panchal D,
et al: Characterization of lymphomas developing in immunodeficient
mice implanted with primary human non-small cell lung cancer. J
Thorac Oncol. 7:1101–1108. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Chen K, Ahmed S, Adeyi O, Dick JE and
Ghanekar A: Humansolid tumor xenografts in immunodeficient mice are
vulnerable to lymphomagenesis associated with epstein-barr virus.
PLoS One. 7:e392942012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Parker C, Milosevic M, Panzarella T,
Banerjee D, Jewett M, Catton C, Tew-George B, Gospodarowicz M and
Warde P: The prognostic significance of the tumour infiltrating
lymphocyte count in stage I testicular seminoma managed by
surveillance. Eur J Cancer. 38:2014–2019. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Salgado R, Denkert C, Demaria S, Sirtaine
N, Klauschen F, Pruneri G, Wienert S, Van den Eynden G, Baehner FL,
Penault-Llorca F, et al: The evaluation of tumor-infiltrating
lymphocytes (TILs) in breast cancer: Recommendations by an
international TILs working group 2014. Ann Oncol. 26:259–271. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Fujii E, Kato A, Chen YJ, Matsubara K,
Ohnishi Y and Suzuki M: Characterization of EBV-related
lymphoproliferative lesions arising in donor lymphocytes of
transplanted human tumor tissues in the NOG mouse. Exp Anim.
63:289–296. 2014. View Article : Google Scholar : PubMed/NCBI
|
